Trials / Unknown
UnknownNCT00497211
Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University Hospital, Antwerp · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Large acute myocardial infarctions are the most frequent cause of subsequent systolic heart failure. Some evidence exists on the improvement after intracoronary administration of bone marrow cells in patients with a recente acute myocardial infarction. Although subgroup analyses suggest that patients with the largest myocardial infarctions have the largest increase in ejection fraction after intracoronary bone marrow administration, there is no published trial including only large myocardial infarctions. Therefor we sought to confirm the subgroup analyses by conducting a trial in only large first acute myocardial infarction patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intracoronary mononuclear cell infusion |
Timeline
- First posted
- 2007-07-06
- Last updated
- 2007-07-06
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00497211. Inclusion in this directory is not an endorsement.